Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)
NCT00280631
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
49
Enrollment
INDUSTRY
Sponsor class
Conditions
Myelodysplastic Syndrome (MDS)
Interventions
DRUG:
Ezatiostat Hydrochlorine
Sponsor
Telik